Vendors search for new options
after COVID serology fails to meet early hype
|
Despite initial
enthusiasm, these assays have struggled to carve out a significant market,
hampered by concerns about test performance and the lack of a clear role in
clinical decision-making. |
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Monday, September 21, 2020
Vendors search for new options after COVID serology fails to meet early hype
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment